FDA Approved: RISPERIDONE — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)

View source ↗

Summary

The FDA approves a supplemental application for generic risperidone by Jubilant Cadista Pharmacuticals Inc., enabling the generic product to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Irritability Associated with Autism
• Schizophrenia

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

SUPPL AP for RISPERIDONE (RISPERIDONE)